For patients with a hungry brain, switching to dual agonists such as tirzepatide (commercially known as Mounjaro), which targets two digestive hormones, GLP-1 and glucose-dependent insulinotropic peptide (GIP) may be useful
A decrease of plasma acid phosphatase and serum alkaline phosphatase occurred by the 10th week in patients with stage C disease presenting with prostatism, showing a major clinical improvement
Andrews, M., Soto, N
These combined actions contribute not only to improved blood sugar regulation but also to substantial and sustained weight loss, offering significant benefits for associated conditions like fatty liver disease, polycystic ovary syndrome (PCOS), and cardiovascular health
The dual-receptor action offers enhanced benefits for blood sugar control and weight management, suppressing appetite and slowing digestion
Subscription Options Both weight loss programs operate on a subscription basis, but the commitment options vary